|Bid||282.74 x 900|
|Ask||282.96 x 800|
|Day's Range||280.48 - 283.44|
|52 Week Range||176.11 - 292.17|
|Beta (3Y Monthly)||1.25|
|PE Ratio (TTM)||60.99|
|Earnings Date||Oct 31, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||291.67|
Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among hedge fund investors have historically outperformed the market after […]
WESTBROOK, Maine , Oct. 10, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled ...
This is the second of two stories that Investopedia is devoting to a report from Goldman Sachs recommending stocks with longterm stable profit growth.
WESTBROOK, Maine , Oct. 2, 2019 /CNW/ -- IDEXX Laboratories, Inc. (IDXX), a global leader in veterinary diagnostics and software, today announced that SDMA-based chronic kidney disease (CKD) staging guidelines have now been generated and approved by the International Renal Interest Society (IRIS). IDEXX is working with IRIS to support clinicians in realizing the clinical utility of the SDMA test and in creating tools that help shape the future of veterinary medicine and patient care.
For many, the main point of investing in the stock market is to achieve spectacular returns. And highest quality...
Shares of medical stocks Idexx Laboratories and Masimo approached breakouts Friday as Wall Street enjoyed a third day of gains. Both stocks are now in the process of forming flat bases.
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
IDEXX Laboratories and Zoetis Inc. appear ready to trade higher, offering stable opportunities as the dog-eat-dog trade war lingers on.
Interim President & CEO of Idexx Laboratories Inc (30-Year Financial, Insider Trades) Jay Mazelsky (insider trades) sold 10,000 shares of IDXX on 08/05/2019 at an average price of $258.4 a share. Continue reading...
WESTBROOK, Maine , Aug. 6, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will host ...
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
With markets again being roiled by international trade tensions, assessing strategies that could prove immune to trade disruptions is an idea to consider. Pet care and the ProShares Pet Care ETF (CBOE: ...